Here’s a bold statement: What if we could slash the risk of type 2 diabetes by more than half? It sounds almost too good to be true, but groundbreaking research from Deakin University is turning this possibility into a reality. And this is the part most people miss: it’s not just about delaying the onset of diabetes—it’s about reversing the condition entirely for some individuals.
For years, prediabetes has been viewed as an inevitable stepping stone to type 2 diabetes. But a global study led by Deakin’s Institute for Physical and Mental Health and Clinical Translation (IMPACT) challenges this long-held belief. The research reveals that individuals with prediabetes who successfully restore their blood sugar levels to normal can reduce their risk of developing type 2 diabetes by a staggering 51%. That’s not just a statistic—it’s a game-changer for millions of people worldwide.
But here’s where it gets controversial: While current clinical guidelines focus on delaying diabetes, this study suggests a more proactive approach—treating prediabetes as a reversible condition. Could this shift in perspective revolutionize how we tackle one of the world’s most pressing health crises?
Prediabetes affects approximately 2 million Australian adults, with blood sugar levels higher than normal but not yet in the diabetic range. Alarmingly, about 1 in 10 of these individuals progress to type 2 diabetes each year. The economic burden is equally staggering, costing Australia roughly $9.1 billion annually. Without intervention, Diabetes Australia warns that up to 3.6 million people could be living with diabetes by 2050. These numbers aren’t just alarming—they’re a call to action.
Managing blood sugar isn’t just a physical challenge; it’s a complex issue that can deeply impact mental health, work readiness, and overall quality of life. For many, it’s a daily struggle that requires constant vigilance and support. But the Deakin study offers a glimmer of hope, suggesting that reversal is not only possible but achievable through targeted interventions.
Led by graduate researcher Dr. Najmeh Davoodian and her supervisor Associate Professor Mohammadreza Mohebbi, the study tracked 8,000 individuals with prediabetes across Australia, Asia, and the United States over several years. The findings, published in Diabetologia, highlight the power of restoring normal blood sugar levels as a primary goal in prediabetes management.
And this is where it gets even more intriguing: The benefits were most pronounced in individuals with healthy cardiometabolic profiles—normal blood pressure, cholesterol, body weight, and waist measurements. For example, non-smokers and those with a healthy body mass index saw their risk plummet by up to 80–85%. Conversely, participants who remained prediabetic saw their risk of developing type 2 diabetes double, even after accounting for other health factors. This underscores the importance of addressing prediabetes as part of a holistic approach to health.
Dr. Davoodian’s message is clear: “We need to stop thinking of prediabetes as a slow march toward diabetes and start treating it as a reversible condition.” Her team is urging doctors and health organizations to update medical guidelines, making blood sugar normalization and cardiometabolic health management a central focus in patient care.
Here’s a thought-provoking question for you: If prediabetes can be reversed for some, why aren’t we doing more to prioritize this approach? Is it a matter of awareness, resources, or a shift in mindset? Share your thoughts in the comments—this is a conversation that could shape the future of diabetes prevention.
For more details, you can explore the study by Najmeh Davoodian et al., Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes, published in Diabetologia (2025). DOI: 10.1007/s00125-025-06555-8.
This article is based on information retrieved from Medical Xpress on November 13, 2025. The content is provided for informational purposes only and is subject to copyright. Reproduction without permission is prohibited.
